Pexels
Scientists at University College London have developed the first gene-silencing drug for Alzheimer's disease. According to a recent article, the drug targets a specific gene, called "presenilin 1," that is known to be involved in the development of Alzheimer's. In a preclinical study, the drug was able to reduce the levels of the protein associated with Alzheimer's by up to 60%, with no adverse effects on other genes.
